SCHEMBL17035245

SCHEMBL17035245

Cc1cccc(-n2c(=O)c(N)c(C)n2C)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.71
PTGS2 P35354 1/20 0.71
ALDH1A1 P00352 4/20 0.45
ALOX15 P16050 2/20 0.45
HSP90AA1 P07900 1/20 0.45
MGLL Q99685 1/20 0.45
LMNA P02545 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 2/20 0.43
CYP1A2 P05177 1/20 0.43
THRB P10828 1/20 0.43
NAPRT Q6XQN6 1/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
PAX8 Q06710 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823375 0.86 BCHE (0.69) BCHEPTGS2ALDH1A1ALOX15LMNA
SCHEMBL17034707 0.83 BCHE (0.65) BCHEPTGS2ALDH1A1ALOX15MGLL
Ampyrone SCHEMBL11674586 0.83 BCHE (1.00) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
Ampyrone SCHEMBL128544 0.83 BCHE (1.00) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
Ampyrone SCHEMBL18159502 0.83 BCHE (1.00) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
SCHEMBL23401173 0.83 BCHE (0.59) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
SCHEMBL23400760 0.83 BCHE (0.59) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
Ampyrone SCHEMBL10746988 0.81 BCHE (0.96) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
Ampyrone SCHEMBL1830291 0.81 BCHE (0.96) BCHEPTGS2ALDH1A1ALOX15HSP90AA1
SCHEMBL18334470 0.81 PTGS2 (0.61) BCHEPTGS2ALDH1A1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170107207-A1 AMINOPYRAZOLONE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170107207-A1 AMINOPYRAZOLONE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170107207-A1 AMINOPYRAZOLONE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170088546-A1 CARBOXAMIDE INHIBITORS NOVARTIS AG (CH) 2017-03-30 US disclosed
US-20170088546-A1 CARBOXAMIDE INHIBITORS NOVARTIS AG (CH) 2017-03-30 US disclosed
US-20170088546-A1 CARBOXAMIDE INHIBITORS NOVARTIS AG (CH) 2017-03-30 US disclosed
EP-3109239-A1 AMINOPYRAZOLONE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-12-28 EP disclosed
WO-2015173659-A2 CARBOXAMIDE DERIVATIVES NOVARTIS AG (CH) 2015-11-19 WO disclosed
WO-2015125786-A1 AMINOPYRAZOLONE DERIVATIVE 第一三共株式会社 2015-08-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088546-A1 CARBOXAMIDE INHIBITORS SMURF1, SMURF2, SMYD2 BCHE 4333/4885PTGS2 2129/4885ALDH1A1 1440/4885
US-20170107207-A1 AMINOPYRAZOLONE DERIVATIVE ATAD5, ATP1A1, TIPRL BCHE 4205/4885PTGS2 3518/4885ALDH1A1 2821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.